TransCode Therapeutics (RNAZ) Announces 1:33 Reverse Share Split

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. CSX
7. LRCX
8. MRK
9. LVS
10. SAP

Go back to TransCode Therapeutics (RNAZ) Announces 1:33 Reverse Share Split

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

November 25, 2024 7:00 AM EST

Split designed to achieve compliance with Nasdaq minimum bid price requirements

BOSTON, Nov. 25, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ) (TransCode or the Company), the RNA Oncology Company committed to more effectively treating cancer using RNA therapeutics, today announced that its Board of Directors has approved a 1-for-33 reverse stock split. The reverse stock split was approved by TransCodes stockholders on November 22, 2024, and is intended to increase the per share trading price of the Company's common stock to enable the Company to satisfy the minimum bid price requirement for... More